Jocasta Neuroscience, a Scottsdale, AZ-based company advancing a longevity protein program for managing cognitive impairment, raised $35 million in a Series A fundraising round led by True Ventures with participation from Moore Strategic Ventures, SC8 Investments, and others.
More on VC News Daily →


